HomeNewsBusinessEconomyIndia Inc needs a work-from-home rejig for leave policies

India Inc needs a work-from-home rejig for leave policies

Amidst remote working due to the coronavirus-led lockdown, Indian companies seem to be subtly indicating to staff that sick leaves are to be largely avoided unless there is a serious ailment or hospitalisation.

July 25, 2020 / 09:49 IST
Story continues below Advertisement

Banker Sumit Awasthi’s boss gave him a blank expression when he messaged him that he would not be able to attend the daily review since he was unwell.

“But you are at home, why can’t you attend a call,” was the boss’ reply 10 minutes later.

Story continues below Advertisement

The message was clear: no sick leaves during remote working.

Amidst remote working due to the coronavirus-led lockdown, Indian companies seem to be subtly indicating to staff that sick leaves are to be largely avoided unless there is a case of hospitalisation due to COVID-19.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show